Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.

peer reviewed ; INTRODUCTION: A substantial proportion of SGA patients present with a syndrome underlying their growth restriction. Most SGA cohorts comprise both syndromic and non-syndromic patients impeding delineation of the recombinant human growth hormone (rhGH) response. We present a detailed characterization of a SGA cohort and analyze rhGH response based on adult height (AH). METHODS: Clinical and auxological data of SGA patients treated with rhGH, who had reached AH, were retrieved from BELGROW, a national database of all rhGH treated patients held by BESPEED (BElgian Society for PEdi... Mehr ...

Verfasser: Becker, Marianne
Thomas, Muriel
Brachet, Cécile
Heinrichs, Claudine
Dotremont, Hilde
De Schepper, Jean
Lysy, Philippe
Beckers, Dominique",BESPEED
Dokumenttyp: journal article
Erscheinungsdatum: 2023
Verlag/Hrsg.: Frontiers Media S.A.
Schlagwörter: Growth Hormone / Human Growth Hormone / Recombinant Proteins / Infant / Newborn / Female / Adult / Humans / Child / Human Growth Hormone/therapeutic use / Belgium/epidemiology / Gestational Age / Fetal Growth Retardation/drug therapy / Diseases/drug therapy / adult height / children / growth / short for gestational age / short stature / syndromic / Human health sciences / Endocrinology / metabolism & nutrition / Pediatrics / Sciences de la santé humaine / Endocrinologie / métabolisme & nutrition / Pédiatrie
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26504364
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/311585